Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984436 · ClinicalTrials.gov registry record
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 1,572
- Enrollment target
NCT02984436 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 1,572 participants.
The verdict
NCT02984436 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 1,572 participants
- Enrollment target
Study Summary
This is a prospective observational cohort study of ED patients with acute chest pain or other symptoms suggestive of ACS. Blood samples will be collected from study participants for High-Sensitivity Cardiac Troponin T (hs-cTnT) analysis. Results from hs-cTnT will be used for research purposes only. Providers will be blinded to results and participants will be treated by their healthcare providers per the standard of care. Participants will have 30 and 90 day phone follow-ups to ascertain study outcomes.
Interventions
- PROCEDURE Blood Sample
- BEHAVIORAL HEART Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,572 participants |
| Start Date | 2017-01-25 |
| Est. Completion | 2020-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02984436
The ClinicalTrials.gov registry entry for NCT02984436 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,572 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Sample is the first listed.
NCT02984436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02984436 about?
NCT02984436 is a clinical study titled "High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification". This is a prospective observational cohort study of ED patients with acute chest pain or other symptoms suggestive of ACS. Blood samples will be collected from study participants for High-Sensitivity Cardiac Troponin T (hs-cTnT) analysis. Results from hs-cTnT will be used for research purposes only....
What is the current status of trial NCT02984436?
This trial is currently completed. The enrollment target is 1,572 participants. The study started on 2017-01-25. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT02984436?
The interventions under investigation include: Blood Sample (PROCEDURE), HEART Score (BEHAVIORAL).
Who is sponsoring clinical trial NCT02984436?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.